Recent Updates
Recently added Catalysts
RLAY

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

Key Takeaway: CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management

Full Press Release Details

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in three upcoming fireside chats:
TD Cowen’s 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ET
Leerink Partners’ 2024 Global Biopharma Conference on Monday, March 11, 2024 at 10:40 a.m. ET
Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 7:30 a.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Last updated: Feb 26, 2024